←Back to Expert Scholars
Translational Medicine / 转化医学KRAS Combination Therapy
Martin Schuler
MD
🏢University Hospital Essen🌐Germany
Professor and Director of Medical Oncology
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Martin Schuler is a medical oncologist leading clinical trials in lung cancer including KRAS G12C inhibitor and combination studies. His work contributes to European phase 1 and 2 trials of next generation KRAS targeting strategies. He advances precision oncology across thoracic malignancies.
Share:
🧪Research Fields 研究领域
lung cancer
KRAS
precision oncology
clinical trials
combination therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Martin Schuler 的研究动态
Follow Martin Schuler's research updates
留下邮箱，当我们发布与 Martin Schuler（University Hospital Essen）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment